Elevating pancreatic cystic lesion stratification: Current and future pancreatic cancer biomarker(s)

Pancreatic ductal adenocarcinoma (PDAC) is an incredibly deadly disease with a 5-year survival rate of 9%. The presence of pancreatic cystic lesions (PCLs) confers an increased likelihood of future pancreatic cancer in patients placing them in a high-risk category. Discerning concurrent malignancy a...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Biochim Biophys Acta Rev Cancer
Asıl Yazarlar: Carmicheal, Joseph, Patel, Asish, Dalal, Vipin, Atri, Pranita, Dhaliwal, Amaninder S., Wittel, Uwe A., Malafa, Mokenge P., Talmon, Geoffrey, Swanson, Benjamin J., Singh, Shailender, Jain, Maneesh, Kaur, Sukhwinder, Batra, Surinder K.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2019
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6980327/
https://ncbi.nlm.nih.gov/pubmed/31676330
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbcan.2019.188318
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller